Propranolol and Primidone demonstrate efficacy in up to 70% of patients as first-line agents. MR-Guided Focused Ultrasound (MRgFUS) results in approximately 56% tremor reduction at 4 years. Deep Brain ...
Praxis Precision Medicines saw its stock soar by 100% on Thursday, following encouraging late-stage results for its experimental essential tremor treatment, ulixacaltamide. The Boston-based biotech ...
HONOLULU — New imaging data may explain how transcutaneous afferent patterned stimulation (TAPS), a noninvasive, wearable therapy, works in patients with essential tremor (ET). In a small study that ...
About a decade ago, Joan Riggs, a 64-year-old from Lemoyne, started to have shaky hands. At first, it was an annoyance. However, as the tremors worsened, they kept her from doing the activities she ...
Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...
DETROIT (WXYZ) — For people living with tremors, even the smallest tasks can feel impossible: signing your name, buttoning a shirt, holding a drink without spilling ...
When Joyce Clifton was just 50 years old, she noticed she could no longer write on a chalkboard because of her shaky hands. Joyce and her husband, Chuck, in Hawaii At first, Clifton wasn’t overly ...
BOSTON--(BUSINESS WIRE)--Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results